Circ_0057105 promotes intrahepatic cholangiocarcinoma progression by sponging miR-1290 and regulating the MDM2/P53 pathway
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Taiyang Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Center, Department of Hepatobiliary Surgery, People's Hospital of Zhengzhou University, Zhengzhou 450003, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Proto-Oncogene Proteins c-mdm2, MicroRNAs, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Henan Provincial People's Hospital.
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (ICC) is a highly aggressive malignancy with limited treatment options, underscoring the need to identify new regulatory molecules. Through high-throughput sequencing of five paired ICC and adjacent normal tissues, we identified a significantly upregulated circular RNA, circ_0057105, which is further validated in ICC cell lines and clinical samples. A correlation between elevated circ_0057105 expression and poor prognosis in ICC patients was observed based on clinical data. Functional in vitro and in vivo assays demonstrated that circ_0057105 promotes ICC cell proliferation, migration, and invasion. Mechanistically, circ_0057105 functions as a competing endogenous RNA (ceRNA) that sponges miR-1290, leading to the upregulation of MDM2. This subsequently enhances MDM2-mediated ubiquitination and degradation of the tumor suppressor p53, thereby inhibiting the p53 signaling pathway. Furthermore, in vivo delivery of small interfering RNA targeting circ_0057105 (si-circ_0057105) encapsulated in lipid nanoparticles (LNPs) effectively suppressed its expression and showed promising therapeutic efficacy. In conclusion, our study demonstrates that circ_0057105 drives ICC progression via the miR-1290-MDM2-p53 axis, establishing it as a valuable prognostic biomarker and a promising therapeutic target. The delivery of siRNA targeting circ_0057105 via lipid nanoparticles represents a potential translational strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatobiliary Center, Department of Hepatobiliary Surgery, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
- Department of General Surgery, Institute of General Surgical Research, Jiangnan University, Medical Center, School of Medicine, Jiangnan University, Wuxi 214023, China.
- Department of Plastic Surgery, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Erqi District, Zhengzhou City, Henan Province 450052, China. Electronic address: kn1977@126.com.
- The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, PR China. Electronic address: hxp11297536@163.com.
- Hepatobiliary Center, Department of Hepatobiliary Surgery, People's Hospital of Zhengzhou University, Zhengzhou 450003, China; Zhengzhou Key Laboratory of Minimally Invasive Treatment of Liver Cancer, Zhengzhou, China.…
Förderung
- Henan Provincial People's Hospital
Zitieren
APA
Chen, T., Wang, Y., Xie, C., Li, Y., Li, Q., Wang, B., Li, J., Xu, Y., Zhou, G., Zhang, K., Kang, N., Hao, X., & Yu, H. (2026). Circ_0057105 promotes intrahepatic cholangiocarcinoma progression by sponging miR-1290 and regulating the MDM2/P53 pathway. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112447
Vancouver
Chen T, Wang Y, Xie C, Li Y, Li Q, Wang B, et al. Circ_0057105 promotes intrahepatic cholangiocarcinoma progression by sponging miR-1290 and regulating the MDM2/P53 pathway. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112447
BibTeX
@article{Chen2026,
author = {Chen, Taiyang and Wang, Yangyang and Xie, Chenxi and Li, Yongshan and Li, Qingshan and Wang, Bo and Li, Jie and Xu, Yang and Zhou, Gengping and Zhang, Kai and Kang, Ning and Hao, Xiaopei and Yu, Haibo},
title = {Circ_0057105 promotes intrahepatic cholangiocarcinoma progression by sponging miR-1290 and regulating the MDM2/P53 pathway},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112447}
}
EUVIMED